1
|
Isonicotinoyl-butanoic acid hydrazone derivatives as anti-tubercular agents: In-silico studies, synthesis, spectral characterization and biological evaluation. Med Chem Res 2023. [DOI: 10.1007/s00044-023-03039-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/06/2023]
|
2
|
Bonde C, Gawad J, Bonde S. Insights into development of Decaprenyl-phosphoryl-β-D-ribose 2'-epimerase (DprE1) inhibitors as antitubercular agents: A state of the art review. Indian J Tuberc 2022; 69:404-420. [PMID: 36460369 DOI: 10.1016/j.ijtb.2021.09.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2021] [Revised: 08/16/2021] [Accepted: 09/06/2021] [Indexed: 06/17/2023]
Abstract
Mycobacterium tuberculosis is a causative agent for the world threatening infectious disease known as tuberculosis. M. tuberculosis is also referred as Koch's bacillus as it was first defined by Robert Koch in 1821. In the entire history of M. tuberculosis infection, several different targets were identified and explored with a hope of effective therapeutic treatment against tuberculosis. Drug-resistant tuberculosis is the major obstacle for researchers and letting them fail continuously to discover new drug candidates. Among the numerous antitubercular targets, Decaprenyl-phosphoryl-β-D-ribose-2'-epimerase (DprE1) is novel target identified in the year 2009. The present article portrays insights of DprE1 enzyme in all the aspects i.e., identification, structural elucidation to designing strategies and synthesis of potential drug candidates to combat resistant strains. Along with the synthesis and biological activity of novel compounds, structure-activity relationship (SAR) data is given to help medicinal chemists and researchers working in this area for the development of new inhibitors to fight against M. tuberculosis. DprE1 is new ray of hope for antitubercular treatment. No single drug candidate (DprE1 inhibitor) has passed clinical trial yet and hence it nullifies the risk of development of resistance or mutations at specific residues. Researchers working in this area have to design and come up with new potent candidates with less dose, no toxicity to combat this deadly infection. This review emphasized on year wise systematic development and progress of DprE1 inhibitors.
Collapse
Affiliation(s)
- Chandrakant Bonde
- Department of Pharmaceutical Chemistry, SVKM's NMIMS School of Pharmacy and Technology Management, Shirpur Campus, MS, 425 405, India
| | - Jineetkumar Gawad
- Department of Pharmaceutical Chemistry, SVKM's NMIMS School of Pharmacy and Technology Management, Shirpur Campus, MS, 425 405, India.
| | - Smita Bonde
- Department of Pharmaceutical Chemistry, SVKM's NMIMS School of Pharmacy and Technology Management, Shirpur Campus, MS, 425 405, India
| |
Collapse
|
3
|
Hebade MJ, Dhumal ST, Kamble SS, Deshmukh TR, Khedkar VM, Hese SV, Gacche RN, Dawane BS. DTP/SiO 2 Assisted Synthesis of New Benzimidazole-Thiazole Conjugates Targeting Antitubercular and Antioxidant Activities. Polycycl Aromat Compd 2022. [DOI: 10.1080/10406638.2022.2056210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- Madhav J. Hebade
- Department of Chemistry, Badrinarayan Barwale Mahavidyalaya, Jalna, Maharashtra, India
| | - Sambhaji T. Dhumal
- Department of Chemistry, Ramkrishna Paramhansa Mahavidyalaya, Osmanabad, Maharashtra, India
| | - Sonali S. Kamble
- Department of Biochemistry, Gramin Science (Vocational) College, Nanded, Maharashtra, India
| | - Tejshri R. Deshmukh
- Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, India
| | - Vijay M. Khedkar
- Department of Pharmaceutical Chemistry, School of Pharmacy, Vishwakarma University, Pune, Maharashtra, India
| | - Shrikant V. Hese
- Department of Chemistry, D. D. Bhoyar College of Arts and Science Mouda, Nagpur, India
| | - Rajesh N. Gacche
- Department of Biotechnology, Savitribai Phule Pune University, Pune, Maharashtra, India
| | - Bhaskar S. Dawane
- School of Chemical Sciences, Swami Ramanand Teerth Marathwada University, Nanded, India
| |
Collapse
|
4
|
Sampiron EG, Costacurta GF, Calsavara LL, Baldin VP, Silva GVD, Alves Olher VG, Ferraretto LH, Caleffi-Ferraciolli KR, Cardoso RF, Siqueira VLD, Vandresen F, Scodro RBDL. In Vitro and In Silico Evaluations of Anti- Mycobacterium tuberculosis Activity of Benzohydrazones Compounds. Microb Drug Resist 2021; 27:1564-1577. [PMID: 33913749 DOI: 10.1089/mdr.2020.0392] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Tuberculosis is a disease caused by Mycobacterium tuberculosis, with high mortality rates and an extended treatment that causes severe adverse effects, besides the emergence of resistant bacteria. Therefore, the search for new compounds with anti-M. tuberculosis activity has considerably increased in recent years. In this context, benzohydrazones are significant compounds that have antifungal and antibacterial action. This study aimed at evaluating the in vitro activity of 18 benzohydrazones against M. tuberculosis. Compounds' cytotoxicity, inhibition of M. tuberculosis efflux pumps, and in silico absorption, distribution, metabolism, excretion, and toxicity (ADMET) assays were also performed. In general, the minimum inhibitory concentration values for the standard M. tuberculosis H37Rv strain ranged from 7.8 to 250 μg/mL, and some compounds were not toxic to any of the cells tested (IC50 ranged from 18.0 to 302.5 μg/mL). In addition, compounds (4) and (7) showed to be possible efflux pump inhibitors. In ADMET assays, all benzohydrazones had high gastrointestinal absorption. Most of the compounds were able to overcome the blood-brain barrier, and no compounds had irritant or tumorigenic effects. Compounds (1), (3), (9), (12), and (15) stood out for showing good activities, both in vitro and in silico assays.
Collapse
Affiliation(s)
- Eloísa Gibin Sampiron
- Postgraduate Program in Health Sciences, State University of Maringá, Maringá, Brazil
| | | | - Leonora Lacerda Calsavara
- Postgraduate Program in Bioscience and Physiopathology, State University of Maringá, Maringá, Brazil
| | - Vanessa Pietrowski Baldin
- Postgraduate Program in Bioscience and Physiopathology, State University of Maringá, Maringá, Brazil
| | - Gabrielle Vaz da Silva
- Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá, Brazil
| | | | | | - Katiany Rizzieri Caleffi-Ferraciolli
- Postgraduate Program in Bioscience and Physiopathology, State University of Maringá, Maringá, Brazil.,Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá, Brazil
| | - Rosilene Fressatti Cardoso
- Postgraduate Program in Health Sciences, State University of Maringá, Maringá, Brazil.,Postgraduate Program in Bioscience and Physiopathology, State University of Maringá, Maringá, Brazil.,Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá, Brazil
| | - Vera Lucia Dias Siqueira
- Postgraduate Program in Bioscience and Physiopathology, State University of Maringá, Maringá, Brazil.,Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá, Brazil
| | - Fábio Vandresen
- Department of Chemistry, Federal Technologic University of Paraná, Londrina, Brazil
| | - Regiane Bertin de Lima Scodro
- Postgraduate Program in Health Sciences, State University of Maringá, Maringá, Brazil.,Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá, Brazil
| |
Collapse
|
5
|
Atukuri D, Gunjal R, Holagundi N, Korlahalli B, Gangannavar S, Akkasali K. Contribution of N-heterocycles towards anti-tubercular drug discovery (2014-2019); predicted and reengineered molecular frameworks. Drug Dev Res 2021; 82:767-783. [PMID: 33660325 DOI: 10.1002/ddr.21809] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2020] [Revised: 02/13/2021] [Accepted: 02/18/2021] [Indexed: 11/08/2022]
Abstract
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis, responsible for high death frequency every year all over the world. In this regard, efficient drug-design and discovery towards the prevention of M.tb H37 Rv is of prime concern. Prevention of the infection may include vaccination, and the treatment comprises anti-TB drug regimen. However, the vaccine decreases the risk of tuberculosis infection only to some extent, while drug-resistance limits the efficacy of the existing anti-TB agents. Much improvement has to be achieved to overcome pitfalls such as side effects, high-toxicity, low bioavailability, pharmacokinetics and pharmacodynamics, and hence forth in clinical therapeutics. Amongst heterocyclic compounds, N-heterocycles played a pivotal role in drug-design and discovery. A wide range of microbial diseases are being treated by the N-heterocyclic drugs. The present review comprises description of anti-TB effects of the N-heterocycles such as indoles, triazoles, thiazoles, and pyrazoles. The potent anti-TB activity exerted by the derivatives of these heterocycles is evaluated critically alongside emphasizing structure-activity relationship. Besides, docking studies supporting anti-TB activity is supplemented. Alongside this, based on the potent heterocyclic molecules, the molecular frameworks are designed that would bring about enhanced M. tb H37 Rv inhibitory potencies.
Collapse
Affiliation(s)
- Dorababu Atukuri
- Department of Chemistry, SRMPP Govt. First Grade College, Huvinahadagali, India
| | - Rutu Gunjal
- Department of Chemistry, SRMPP Govt. First Grade College, Huvinahadagali, India
| | - Nagaraj Holagundi
- Department of Chemistry, SRMPP Govt. First Grade College, Huvinahadagali, India
| | | | | | - Kirankumar Akkasali
- Department of Chemistry, SRMPP Govt. First Grade College, Huvinahadagali, India
| |
Collapse
|
6
|
Ramachandran E, Gandin V, Bertani R, Sgarbossa P, Natarajan K, Bhuvanesh NSP, Venzo A, Zoleo A, Mozzon M, Dolmella A, Albinati A, Castellano C, Reis Conceição N, C. Guedes da Silva MF, Marzano C. Synthesis, Characterization and Biological Activity of Novel Cu(II) Complexes of 6-Methyl-2-Oxo-1,2-Dihydroquinoline-3-Carbaldehyde-4n-Substituted Thiosemicarbazones. Molecules 2020; 25:E1868. [PMID: 32316698 PMCID: PMC7221752 DOI: 10.3390/molecules25081868] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2020] [Revised: 04/11/2020] [Accepted: 04/13/2020] [Indexed: 02/06/2023] Open
Abstract
Three new 6-methyl-2-oxo-1,2-dihydroquinoline-3-carbaldehyde-thiosemicarbazones-N-4-substituted pro-ligands and their Cu(II) complexes (1, -NH2; 2, -NHMe; 3, -NHEt) have been prepared and characterized. In both the X-ray structures of 1 and 3, two crystallographically independent complex molecules were found that differ either in the nature of weakly metal-binding species (water in 1a and nitrate in 1b) or in the co-ligand (water in 3a and methanol in 3b). Electron Paramagnetic Resonance (EPR) measurements carried out on complexes 1 and 3 confirmed the presence of such different species in the solution. The electrochemical behavior of the pro-ligands and of the complexes was investigated, as well as their biological activity. Complexes 2 and 3 exhibited a high cytotoxicity against human tumor cells and 3D spheroids derived from solid tumors, related to the high cellular uptake. Complexes 2 and 3 also showed a high selectivity towards cancerous cell lines with respect to non-cancerous cell lines and were able to circumvent cisplatin resistance. Via the Transmission Electron Microscopy (TEM) imaging technique, preliminary insights into the biological activity of copper complexes were obtained.
Collapse
Affiliation(s)
- Eswaran Ramachandran
- Department of Industrial Engineering, University of Padova, 35131 Padova, Italy; (E.R.); (R.B.); (M.M.)
- Chemistry Research Center, National Engineering College, K. R. Nagar, Kovilpatti, Tamilnadu 628503, India
| | - Valentina Gandin
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy; (V.G.); (A.D.); (C.M.)
| | - Roberta Bertani
- Department of Industrial Engineering, University of Padova, 35131 Padova, Italy; (E.R.); (R.B.); (M.M.)
| | - Paolo Sgarbossa
- Department of Industrial Engineering, University of Padova, 35131 Padova, Italy; (E.R.); (R.B.); (M.M.)
| | - Karuppannan Natarajan
- Department of Chemistry, Sri Ramakrishna Mission Vidyalaya College of Arts and Science, Coimbatore, Tamil Nadu 641020, India
| | | | - Alfonso Venzo
- Department of Chemical Sciences, University of Padova, 35131 Padova, Italy; (A.V.); (A.Z.)
| | - Alfonso Zoleo
- Department of Chemical Sciences, University of Padova, 35131 Padova, Italy; (A.V.); (A.Z.)
| | - Mirto Mozzon
- Department of Industrial Engineering, University of Padova, 35131 Padova, Italy; (E.R.); (R.B.); (M.M.)
| | - Alessandro Dolmella
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy; (V.G.); (A.D.); (C.M.)
| | - Alberto Albinati
- Department of Chemistry, University of Milan, 20133 Milan, Italy; (A.A.); (C.C.)
| | - Carlo Castellano
- Department of Chemistry, University of Milan, 20133 Milan, Italy; (A.A.); (C.C.)
| | - Nuno Reis Conceição
- Centro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisboa, Portugal; (N.R.C.); (M.F.C.G.d.S.)
| | - M. Fátima C. Guedes da Silva
- Centro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisboa, Portugal; (N.R.C.); (M.F.C.G.d.S.)
| | - Cristina Marzano
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy; (V.G.); (A.D.); (C.M.)
| |
Collapse
|
7
|
Maniak H, Talma M, Matyja K, Trusek A, Giurg M. Synthesis and Structure-Activity Relationship Studies of Hydrazide-Hydrazones as Inhibitors of Laccase from Trametes versicolor. Molecules 2020; 25:E1255. [PMID: 32164357 PMCID: PMC7179439 DOI: 10.3390/molecules25051255] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2020] [Revised: 03/04/2020] [Accepted: 03/08/2020] [Indexed: 12/13/2022] Open
Abstract
A series of hydrazide-hydrazones 1-3, the imine derivatives of hydrazides and aldehydes bearing benzene rings, were screened as inhibitors of laccase from Trametes versicolor. Laccase is a copper-containing enzyme which inhibition might prevent or reduce the activity of the plant pathogens that produce it in various biochemical processes. The kinetic and molecular modeling studies were performed and for selected compounds, the docking results were discussed. Seven 4-hydroxybenzhydrazide (4-HBAH) derivatives exhibited micromolar activity Ki = 24-674 µM with the predicted and desirable competitive type of inhibition. The structure-activity relationship (SAR) analysis revealed that a slim salicylic aldehyde framework had a pivotal role in stabilization of the molecules near the substrate docking site. Furthermore, the presence of phenyl and bulky tert-butyl substituents in position 3 in salicylic aldehyde fragment favored strong interaction with the substrate-binding pocket in laccase. Both 3- and 4-HBAH derivatives containing larger 3-tert-butyl-5-methyl- or 3,5-di-tert-butyl-2-hydroxy-benzylidene unit, did not bind to the active site of laccase and, interestingly, acted as non-competitive (Ki = 32.0 µM) or uncompetitive (Ki = 17.9 µM) inhibitors, respectively. From the easily available laccase inhibitors only sodium azide, harmful to environment and non-specific, was over 6 times more active than the above compounds.
Collapse
Affiliation(s)
- Halina Maniak
- Department of Micro, Nano and Bioprocess Engineering, Faculty of Chemistry, Wroclaw University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland; (K.M.); (A.T.)
| | - Michał Talma
- Department of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland;
| | - Konrad Matyja
- Department of Micro, Nano and Bioprocess Engineering, Faculty of Chemistry, Wroclaw University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland; (K.M.); (A.T.)
| | - Anna Trusek
- Department of Micro, Nano and Bioprocess Engineering, Faculty of Chemistry, Wroclaw University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland; (K.M.); (A.T.)
| | - Mirosław Giurg
- Department of Organic and Medicinal Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland
| |
Collapse
|
8
|
Yan M, Xu L, Wang Y, Wan J, Liu T, Liu W, Wan Y, Zhang B, Wang R, Li Q. Opportunities and challenges of using five-membered ring compounds as promising antitubercular agents. Drug Dev Res 2020; 81:402-418. [PMID: 31904877 DOI: 10.1002/ddr.21638] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2019] [Revised: 12/07/2019] [Accepted: 12/24/2019] [Indexed: 12/17/2022]
Abstract
Tuberculosis (TB), a chronic infectious disease, is one of the greatest risks to human beings and 10 million people were diagnosed with TB and 1.6 million died from this disease in 2017. In addition, with the emergence of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB), the TB situation has become even worse, which has aggravated the mortality and spread of this disease. To overcome this problem, research into novel antituberculosis agents with enhanced activities against MDR-TB, reduced toxicity, and shortened duration of therapy is of great importance. Fortunately, many novel potential anti-TB drug candidates with five-membered rings, which are most likely to be effective against sensitive and resistant strains, have recently entered clinical trials. Different five-membered rings such as furans, pyranoses, thiazoles, pyrazolines, imidazoles, oxazolidinone, thiazolidins, isoxazoles, triazoles, oxadiazoles, thiadiazoles, and tetrazoles have been designed, prepared, and evaluated for their antimycobacterial activity against Mycobacterium tuberculosis. In this article, we highlight the recent advances made in the discovery of novel five-membered ring compounds and focus on their antitubercular activities, toxicity, structure-activity relationships, and mechanisms of action.
Collapse
Affiliation(s)
- Mi Yan
- Department of Pharmacy, The Second Hospital of Shandong University, Jinan, China
| | - Linlin Xu
- Department of Pharmacy, Taian Central Hospital, Taian, China
| | - Yinhu Wang
- School of Pharmacy, Liaocheng University, Liaocheng, China
| | - Jianhua Wan
- China Resources Land Huabei Region Shandong Company, Jinan, China
| | - Ting Liu
- Department of Laboratory Medical Centre, The Second Hospital of Shandong University, Jinan, China
| | - Wenjie Liu
- Department of Pharmacy, The Second Hospital of Shandong University, Jinan, China
| | - Yichao Wan
- Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, Ministry of Education, Hunan Provincial Key Laboratory of Controllable Preparation and Functional Application of Fine Polymers, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan, China
| | - Bin Zhang
- Department of Pharmacy, The Second Hospital of Shandong University, Jinan, China
| | - Rongmei Wang
- Department of Pharmacy, The Second Hospital of Shandong University, Jinan, China
| | - Qiang Li
- Department of Pharmacy, The Second Hospital of Shandong University, Jinan, China
| |
Collapse
|
9
|
Ertas M, Sahin Z, Bulbul EF, Bender C, Biltekin SN, Berk B, Yurttas L, Nalbur AM, Celik H, Demirayak Ş. Potent ribonucleotide reductase inhibitors: Thiazole-containing thiosemicarbazone derivatives. Arch Pharm (Weinheim) 2019; 352:e1900033. [PMID: 31475759 DOI: 10.1002/ardp.201900033] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2019] [Revised: 07/30/2019] [Accepted: 08/01/2019] [Indexed: 12/12/2022]
Abstract
The antioxidant, antimalarial, antibacterial, and antitumor activities of thiosemicarbazones have made this class of compounds important for medicinal chemists. In addition, thiosemicarbazones are among the most potent and well-known ribonucleotide reductase inhibitors. In this study, 24 new thiosemicarbazone derivatives were synthesized, and the structures and purity of the compounds were determined by IR, 1 H NMR, 13 C NMR, mass spectroscopy, and elemental analysis. The IC50 values of these 24 compounds were determined with an assay for ribonucleotide reductase inhibition. Compounds 19, 20, and 24 inhibited ribonucleotide reductase enzyme activity at a higher level than metisazone as standard. The cytotoxic effects of these compounds were measured on the MCF7 (human breast adenocarcinoma) and HEK293 (human embryonic kidney) cell lines. Similarly, compounds 19, 20, and 24 had a selective effect on the MCF7 and HEK293 cell lines, killing more cancer cells than cisplatin as standard. The compounds (especially 19, 20, and 24 as the most active ones) were then subjected to docking experiments to identify the probable interactions between the ligands and the enzyme active site. The complex formation was shown qualitatively. The ADME (absorption, distribution, metabolism, and excretion) properties of the compounds were analyzed using in-silico techniques.
Collapse
Affiliation(s)
- Merve Ertas
- Department of Pharmaceutical Chemistry, School of Pharmacy, Istanbul Medipol University, Istanbul, Turkey
| | - Zafer Sahin
- Department of Pharmaceutical Chemistry, School of Pharmacy, Istanbul Medipol University, Istanbul, Turkey
| | - Emre F Bulbul
- Department of Pharmaceutical Chemistry, School of Pharmacy, Istanbul Medipol University, Istanbul, Turkey
| | - Ceysu Bender
- Department of Pharmaceutical Chemistry, School of Pharmacy, Istanbul Medipol University, Istanbul, Turkey
| | - Sevde N Biltekin
- Department of Pharmaceutical Microbiology, School of Pharmacy, Istanbul Medipol University, Istanbul, Turkey
| | - Barkin Berk
- Department of Pharmaceutical Chemistry, School of Pharmacy, Istanbul Medipol University, Istanbul, Turkey
| | - Leyla Yurttas
- Department of Pharmaceutical Chemistry, School of Pharmacy, Anadolu University, Eskişehir, Turkey
| | - Aysu M Nalbur
- Department of Analytical Chemistry, School of Pharmacy, Yeditepe University, Istanbul, Turkey
| | - Hayati Celik
- Department of Analytical Chemistry, School of Pharmacy, Yeditepe University, Istanbul, Turkey
| | - Şeref Demirayak
- Department of Pharmaceutical Chemistry, School of Pharmacy, Istanbul Medipol University, Istanbul, Turkey
| |
Collapse
|
10
|
Rezki N, Al-Sodies SA, Ahmed HE, Ihmaid S, Messali M, Ahmed S, Aouad MR. A novel dicationic ionic liquids encompassing pyridinium hydrazone-phenoxy conjugates as antimicrobial agents targeting diverse high resistant microbial strains. J Mol Liq 2019. [DOI: 10.1016/j.molliq.2019.04.010] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
11
|
Sharma D, Bansal KK, Sharma A, Pathak M, Sharma PC. A Brief Literature and Review of Patents on Thiazole Related Derivatives. ACTA ACUST UNITED AC 2019. [DOI: 10.2174/1573407214666180827094725] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Background:
Thiazole is widely investigated bioactive scaffold and dynamic tool in medicinal
chemistry research. Significance of thiazole compounds are well documented as thiazole is an
obligatory structure of number of currently available therapeutics. In spite of that, thiazole derivatives
are endowed with myriad biological activities, such as antiviral, anticancer, antibacterial, antifungal,
antimalarial, antiparkinsonian, anti-inflammatory activities and many more.
Methods:
In recent past, different approaches have been introduced for synthesis of thiazole and related
compounds. Intrinsic molecular interaction between newly synthesized thiazole compounds and plethora
of drug targets/enzymes has rendered discovery of new drug molecules with advances in modes of
action. A renewed interest in therapeutic use of thiazole derivatives has been seen among the prospective
researchers as exemplified by influx of huge scientific articles and patents. Some important patents
of anti-infective and anticancer interest have been addressed appropriately and are presented in tables.
Results:
This review paper is a contemporary approach on therapeutic/applications of thiazole derivatives
by summarizing important patents filed from 2000-2017. The main focus of these patents is on
anti-infective and anticancer potential of thiazole based compounds.
Conclusion:
These approaches may provide valuable information for the further design of more active
biological agents through various modifications and derivatizations.
Collapse
Affiliation(s)
- Diksha Sharma
- Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra, Haryana-136119, India
| | - Kushal K. Bansal
- Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra, Haryana-136119, India
| | - Archana Sharma
- Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra, Haryana-136119, India
| | - Meenakshi Pathak
- Pharmacy Australia Center of Excellence, University of Queensland, Woollongabba, Brisbane, QLD 4102, Australia
| | - Prabodh C. Sharma
- Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra, Haryana-136119, India
| |
Collapse
|
12
|
Alizadeh-Bami F, Mehrabi H, Ranjbar-Karimi R. One-pot three-component reaction of arylglyoxals with acetylthiourea and Meldrum’s acid or barbituric acid for synthesis of new 2-acetamido-4-arylthiazol-5-yl derivatives. J Sulphur Chem 2019. [DOI: 10.1080/17415993.2019.1602127] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
| | - Hossein Mehrabi
- Department of Chemistry, Vali-e-Asr University of Rafsanjan, Rafsanjan, Iran
| | - Reza Ranjbar-Karimi
- Department of Chemistry, Vali-e-Asr University of Rafsanjan, Rafsanjan, Iran
| |
Collapse
|
13
|
Thiazolyl-pyrazole derivatives as potential antimycobacterial agents. Bioorg Med Chem Lett 2019; 29:1199-1202. [PMID: 30910461 DOI: 10.1016/j.bmcl.2019.03.020] [Citation(s) in RCA: 42] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2019] [Revised: 03/17/2019] [Accepted: 03/18/2019] [Indexed: 12/13/2022]
Abstract
Mycobacterium tuberculosis (Mtb) is an obligate aerobe that is capable of long-term persistence under conditions of low oxygen tension. A series of thiazolyl-pyrazole derivatives (6a-f, 7a-f, 8c, 8e) were screened for antimycobacterial activity against dormant M. tuberculosis H37Ra (D-MTB) and M. bovis BCG (D-BCG). Nine thiazolyl-pyrazole analogs, 6c, 6e, 7a, 7b, 7c, 7e, 7f, 8c and 8e exhibited promissing minimum inhibitory concentration (MIC) values (0.20-28.25 µg/mL) against D-MTB and D-BCG strains of Mtb. Importantly, six compounds (7a, 7b, 7e, 7f, 8c and 8e) exhibited excellent antimycobacterial activity and low cytotoxicity at the maximum evaluated concentration of >250 µg/mL. Finally, the promising antimycobacterial activity and lower cytotoxicity profile suggested that, these compounds could be further subjected for optimization and development as a lead, which could have the potential to treat tuberculosis.
Collapse
|
14
|
Modi P, Patel S, Chhabria M. Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo[1,5-a]pyrimidine analogues as potential anti-tubercular agents. Bioorg Chem 2019; 87:240-251. [PMID: 30908967 DOI: 10.1016/j.bioorg.2019.02.044] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2018] [Revised: 01/23/2019] [Accepted: 02/20/2019] [Indexed: 11/16/2022]
Abstract
In-depth study of structure-based drug designing can provide vital leads for the development of novel, clinically active molecules. In this present study, twenty six novel pyrazolo[1,5-a]pyrimidine analogues (6a-6z) were designed using molecular docking studies. The designed molecules were synthesized in good yields. Structural elucidation of the synthesized molecules was carried out using IR, MS, 1H NMR and 13C NMR spectroscopy. All the synthesized compounds were evaluated for their in-vitro anti-tubercular activity against H37Rv strain by Alamar Blue assay method. Most of the synthesized compounds displayed potent anti-tubercular activities. Amongst all the tested compounds 6p, 6g, 6n and 6h exhibited promising anti-tubercular activity. Further, these potent compounds were gauged for MDR-TB, XDR-TB and cytotoxic study. None of these compounds exhibited potent cytotoxicity. Stability of protein ligand complex was further evaluated by molecular dynamics simulation for 10 ns. All these results indicate that the synthesized compounds could be potential leads for further development of new potent anti-tubercular agents.
Collapse
Affiliation(s)
- Palmi Modi
- Department of Pharmaceutical Chemistry, L. M. College of Pharmacy, Navrangpura, Ahmedabad, 380009 Gujarat, India; Department of Pharmacy, Dharmsinh Desai University, Nadiad, 387001 Gujarat, India; Department of Pharmaceutical Chemistry, L. J. Institute of Pharmacy, Ahmedabad, 382210 Gujarat, India
| | - Shivani Patel
- Department of Pharmaceutical Chemistry, L. M. College of Pharmacy, Navrangpura, Ahmedabad, 380009 Gujarat, India; Division of Biological and Life Sciences, Ahmedabad University, Ahmedabad, 380009 Gujarat, India
| | - Mahesh Chhabria
- Department of Pharmaceutical Chemistry, L. M. College of Pharmacy, Navrangpura, Ahmedabad, 380009 Gujarat, India.
| |
Collapse
|
15
|
Deshmukh AR, Dhumal ST, Nawale LU, Khedkar VM, Sarkar D, Mane RA. Dicationic liquid mediated synthesis of tetrazoloquinolinyl methoxy phenyl 4-thiazolidinones and their antibacterial and antitubercular evaluation. SYNTHETIC COMMUN 2019. [DOI: 10.1080/00397911.2018.1564928] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- Amarsinh R. Deshmukh
- Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University , Aurangabad , India
| | - Sambhaji T. Dhumal
- Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University , Aurangabad , India
| | - Laxman U. Nawale
- CSIR-National Chemical Laboratory, Combi-Chem Bio Resource Centre , Pune , India
| | - Vijay M. Khedkar
- CSIR-National Chemical Laboratory, Combi-Chem Bio Resource Centre , Pune , India
| | - Dhiman Sarkar
- CSIR-National Chemical Laboratory, Combi-Chem Bio Resource Centre , Pune , India
| | - Ramrao A. Mane
- Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University , Aurangabad , India
| |
Collapse
|
16
|
Ultrasound Assisted Synthesis of 4-(Benzyloxy)- N-(3-chloro-2-(substitutedphenyl)-4-oxoazetidin-1-yl) Benzamide as Challenging Anti-Tubercular Scaffold. Molecules 2018; 23:molecules23081945. [PMID: 30081525 PMCID: PMC6222352 DOI: 10.3390/molecules23081945] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2018] [Revised: 07/13/2018] [Accepted: 07/30/2018] [Indexed: 11/17/2022] Open
Abstract
A series of ten novel derivatives of 4-(benzyloxy)-N-(3-chloro-2-(substituted phenyl)-4-oxoazetidin-1-yl) benzamide 6a⁻j were synthesized in good yield from the key compound 4-(benzyloxy)-N'-(substituted benzylidene) benzo hydrazide, called Schiff 's bases 5a⁻j, by Staudinger reaction ([2 + 2] ketene-imine cycloaddition reaction) with chloro acetyl chloride in the presence of catalyst tri ethylamine and solvent dimethyl formamide (DMF), by using ultra-sonication as one of the green chemistry tools. All the synthesised compounds were evaluated for in vitro anti-tubercular activity against Mycobacterium tuberculosis (MTB) and most of them showed promising activity with an IC50 value of less than 1 µg/mL. To establish the safety, all the synthesized compounds were further tested for cytotoxicity against the human cancer cell line HeLa and all 6a⁻j compounds were found to be non-cytotoxic in nature. The molecular docking study was carried out with essential enzyme InhA (FabI/ENR) of Mycobacterium responsible for cell wall synthesis which suggests that 6a and 6e are the most active derivatives of the series. The theoretical evaluation of cell permeability based on Lipinski's rule of five has helped to rationalize the biological results and hence the synthesized azetidinone derivatives 6a⁻j were also analyzed for physicochemical evaluation that is, absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties and the results showed that all the derivatives could comply with essential features required for a potential lead in the anti-tubercular drug discovery process.
Collapse
|
17
|
Ghani U, Albarrag A, Yurttaş L, Demirci F, Kaplancikli ZA. Carbazoles and Hydrazone‐Bridged Thiazole‐Pyrrole Derivatives as New Inhibitors of α‐Glucosidase. ChemistrySelect 2018. [DOI: 10.1002/slct.201801771] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Affiliation(s)
- Usman Ghani
- Clinical Biochemistry UnitDepartment of PathologyCollege of MedicineKing Saud University Riyadh 11461 Saudi Arabia
| | - Ahmed Albarrag
- Medical Microbiology UnitDepartment of PathologyCollege of MedicineKing Saud University Riyadh 11461 Saudi Arabia
| | - Leyla Yurttaş
- Department of Pharmaceutical ChemistryFaculty of PharmacyAnadolu University 26470 Eskişehir Turkey
| | - Fatih Demirci
- Department of PharmacognosyFaculty of PharmacyAnadolu University 26470 Eskişehir Turkey
| | - Zafer Asim Kaplancikli
- Department of Pharmaceutical ChemistryFaculty of PharmacyAnadolu University 26470 Eskişehir Turkey
| |
Collapse
|
18
|
Nural Y. Synthesis, antimycobacterial activity, and acid dissociation constants of polyfunctionalized 3-[2-(pyrrolidin-1-yl)thiazole-5-carbonyl]-2H-chromen-2-one derivatives. MONATSHEFTE FUR CHEMIE 2018. [DOI: 10.1007/s00706-018-2250-7] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
|
19
|
Nural Y, Gemili M, Ulger M, Sari H, De Coen LM, Sahin E. Synthesis, antimicrobial activity and acid dissociation constants of methyl 5,5-diphenyl-1-(thiazol-2-yl)pyrrolidine-2-carboxylate derivatives. Bioorg Med Chem Lett 2018; 28:942-946. [DOI: 10.1016/j.bmcl.2018.01.045] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2017] [Revised: 01/18/2018] [Accepted: 01/23/2018] [Indexed: 12/19/2022]
|
20
|
Bondock S, Fouda AM. Synthesis and evaluation of some new 5-(hetaryl)thiazoles as potential antimicrobial agents. SYNTHETIC COMMUN 2018. [DOI: 10.1080/00397911.2017.1412465] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Affiliation(s)
- Samir Bondock
- Chemistry Department, Faculty of Science, King Khalid University, Abha, Saudi Arabia
- Chemistry Department, Faculty of Science, Mansoura University, Mansoura, Egypt
| | - Ahmed M. Fouda
- Chemistry Department, Faculty of Science, King Khalid University, Abha, Saudi Arabia
| |
Collapse
|
21
|
Gholap S, Tambe M, Nawale L, Sarkar D, Sangshetti J, Damale M. Design, synthesis, and pharmacological evaluation of fluorinated azoles as anti-tubercular agents. Arch Pharm (Weinheim) 2018; 351. [PMID: 29292534 DOI: 10.1002/ardp.201700294] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2017] [Revised: 11/26/2017] [Accepted: 11/30/2017] [Indexed: 12/30/2022]
Abstract
Design, synthesis, and biological screening of 2,2-dimethyl-2,3-dihydrobenzofuran tethered 1,3,4-oxadiazole derivatives as anti-tubercular agents were described. The synthesis of the target compounds was conducted by a series of reaction schemes. All the synthesized compounds were characterized by IR, 1 H NMR, 13 C NMR, and mass spectrometry. The therapeutic potential of the synthesized compounds was confirmed by molecular docking studies. Among the synthesized compounds, 12a, 12c, 12d, 12e, 12g, and 12j were found to be more active against non-replicating than against replicating cultures of Mycobacterium tuberculosis H37Ra ex vivo and in vitro. These compounds exhibit minimum inhibitory concentration (MIC) values in the range of 2.31-23.91 μg/mL. The cytotoxicity study was conducted against the cell lines THP-1, A549 and PANC-1, and the compounds were observed to be non-toxic to host cells. Molecular docking was conducted with InhA (FabI/ENR) and suggested the antimycobacterial potential of the synthesized compounds. The investigation presented here was found to be adventitious for the development of new therapeutic agents against Mycobacterium infection.
Collapse
Affiliation(s)
- Somnath Gholap
- Postgraduate Department of Chemistry and Research Centre, Padmashri Vikhe Patil College, Pravaranagar, A/P-Loni kd, Tal.-Rahata, Ahmadnagar, India
| | - Macchindra Tambe
- Postgraduate Department of Chemistry and Research Centre, Padmashri Vikhe Patil College, Pravaranagar, A/P-Loni kd, Tal.-Rahata, Ahmadnagar, India
| | - Laxman Nawale
- Division of Organic Chemistry, Combichem-Bioresource Centre, National Chemical Laboratory, Pune, India
| | - Dhiman Sarkar
- Division of Organic Chemistry, Combichem-Bioresource Centre, National Chemical Laboratory, Pune, India
| | | | | |
Collapse
|
22
|
Wang G, Chen M, Wang J, Peng Y, Li L, Xie Z, Deng B, Chen S, Li W. Synthesis, biological evaluation and molecular docking studies of chromone hydrazone derivatives as α -glucosidase inhibitors. Bioorg Med Chem Lett 2017; 27:2957-2961. [DOI: 10.1016/j.bmcl.2017.05.007] [Citation(s) in RCA: 50] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2017] [Revised: 04/27/2017] [Accepted: 05/03/2017] [Indexed: 01/25/2023]
|